CVS Caremark is reversing course on Eli Lilly’s weight loss drugs, adding both its shot and new pill to coverage
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options
المصدر: Quartz
0
مشاهدة